Clinical trial

Furosemide Pharmacodynamics and Pharmacokinetics After Subcutaneous or Oral Administration

NCT02350725

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-12-01

PhasePHASE1 / PHASE2

Study timeline

Study start (unknown)2014-12-01Date precision: month

Registry last updated2018-06-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failureunresolved

Interventions

Furosemide injection solution for subcutaneous administration (80 mg)DRUG

Oral Furosemide tablets (80 mg)DRUG

Sponsors & collaborators

scPharmaceuticals, Inc.lead sponsor

Mapped research locations

GroningenNetherlands1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02350725 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.